Basic Info

DesertSci powers structure-based drug discovery (SBDD) at over 60% of the top 25 global pharma companies - and the majority of the top 10. Our platform Proasis is the industry standard for protein structure data management, visualisation, and analysis, with 98% customer retention to prove it.

Proasis is the industry-leading protein structure database and visualisation system - a centralised single source of truth for high-value protein–ligand and protein–protein structure data. Trusted by the world's leading pharma and biotech organisations, Proasis accelerates SBDD workflows through an integrated suite of cheminformatics and bioinformatics tools, driving faster candidate identification and deeper data-driven insights across both small molecule and biologic programs. Twenty-five years of development, purpose-built for medicinal chemistry.

Key innovations include ViewContacts, our market-leading interaction analysis software; Scorpion, our network-based protein–ligand binding affinity platform; and Viper, our AI-driven tool for automated drug design.

With 98% customer retention across the world's largest and most demanding pharma and biotech organisations, DesertSci delivers proven, lasting value to the multidisciplinary teams driving modern drug discovery.

Why work with us

Why DesertSci?

In a field where data quality and analytical depth directly impact outcomes, the platform you choose matters. Here's what sets DesertSci apart.

  • Purpose-built depth you can't replicate in-house Building and maintaining a protein structure database and analysis platform is a decade-long undertaking. Proasis represents 25 years of continuous development, specifically for SBDD - delivering capabilities that in-house teams and general cheminformatics tools simply can't match without enormous ongoing investment.
  • The industry standard, not a workaround General cheminformatics platforms treat structural biology as one feature among many. Proasis was built from the ground up for protein structure data. This means deeper functionality, better data quality, and workflows designed around how multidisciplinary teams of med chemists, structural biologists and computational chemist, actually work.
  • Scientific credibility backed by real expertise Our team understands the science. DesertSci doesn't just deliver software - we bring deep domain expertise in structural biology, computational chemistry and drug discovery, with support from scientists who speak your language and understand your workflows.
  • Proven at scale, where it matters most Over 60% of the top 25 global pharma companies trust Proasis with their most valuable structural data. Our 98% customer retention rate reflects not just satisfaction, but the difficulty of finding anything that comes close.
  • A long-term partner, not a vendor Drug discovery programs run for years. So do our client relationships. With a 25-year track record and near-universal retention among the world's most demanding research organisations, DesertSci is built for the long haul.

Company focus

Services

Medical Technology & Digital Health
Company Type (Public/Private)
Private

Industries

Biotechnology
Pharmaceuticals

Projects or Case studies (1)

Proasis in action

-

25 years of machine learning - how DesertSci turns the world's messiest protein structure data into a research-ready asset, automatically.

Contacts

Annabelle Kay Avatar

Annabelle Kay

Director - Operations

Neil Taylor Avatar

Neil Taylor

CSO